Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?
Did you know that if you have a high-yielding dividend stock that pays 5%, investing just $20,000 would be enough to generate $1,000 in annual dividend income? High-yielding stocks can be extremely valuable in helping to grow your portfolio.
One top healthcare stock that provides investors with a yield of more than 5% today is Pfizer (NYSE: PFE). Investors have turned bearish on the stock this year, and that has sent its yield up. Here's a closer look at what has investors down on the stock and whether it could potentially be a good buy right now.
On Oct. 13, Pfizer released an updated guidance, and it was all-around bad news for the company's investors. This year, the company projects its top line will be within a range of $58 billion to $61 billion. Previously, the company was expecting its revenue to total between $67 billion and $70 billion. Overall, it amounts to a $9 billion reduction on both the high end and low end of the previous forecast.
Source Fool.com
Pfizer Inc. Stock
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 60.0% compared to the current price of 25.63 € for Pfizer Inc..